Development and validation of machine-learning models of diet management for hyperphenylalaninemia: a multicenter

Yajie Su1,2, Yaqiong Wang1, Jinfeng He3

  • 1Centre for Molecular Medicine, Children's Hospital of Fudan University, and Institutes of Biomedical Sciences, Fudan University, Shanghai, China.

BMC Medicine
|September 10, 2024
PubMed

Insights

This study developed a machine learning model to predict phenylalanine (Phe) intake tolerance in children with hyperphenylalaninemia (HPA), improving dietary management. The model integrates genetic and metabolic data for personalized treatment strategies.

Area of Science:

  • Biochemistry
  • Genetics
  • Computational Biology

Background:

  • Managing hyperphenylalaninemia (HPA) requires careful assessment of dietary phenylalanine (Phe) tolerance.
  • Current dietary management is time-intensive for clinicians and families.

Purpose of the Study:

  • To develop a machine learning model for predicting dietary Phe intake tolerance in children with HPA.
  • To enable precise, personalized dietary management over 10 years post-diagnosis.

Main Methods:

  • Retrospective observational study of 204 children with HPA, collecting genotype, metabolic profiles, and Phe concentrations.
  • Utilized a predicted allelic phenotype value (pAPV) model incorporating 2965 missense variants in the phenylalanine hydroxylase (PAH) gene.
  • Trained a multiclass classification model on metabolic, genetic, and follow-up data, validated using tenfold cross-validation and independent datasets.

Main Results:

  • The pAPV model demonstrated good predictive performance (RMSE 1.53 training, 2.38 test).
  • The final model achieved high sensitivity (0.77-0.91) and specificity (0.8-1) across validation datasets.
  • Robust performance indicated by positive predictive value (0.68-1), negative predictive value (0.8-0.98), F1 score (0.71-0.92), and balanced accuracy (0.8-0.92).

Conclusions:

  • The developed model integrates metabolic and genetic data for accurate, age-specific Phe tolerance prediction in HPA patients.
  • This approach facilitates precision management of HPA and offers a framework for other inborn errors of metabolism.
Abstract